NCT00444704View on ClinicalTrials.gov

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2007

Study Completion Date

December 31, 2007

Conditions

Uterine Leiomyomata (Fibroids)

Interventions

DRUG

PRA-027

Trial Locations (1)

305-0856

Tsukuba

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00444704 - Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females | Biotech Hunter | Biotech Hunter